Investor Ideas #Potcasts #Cannabis News
and #Stocks on the Move: TSX: $APH.TO,
TSX: $TRST.TO, TSX: $CHH.TO, TSX: $WEED.TO, TSXV: $N.V
Delta, Kelowna, BC –September 5, 2018
(Investorideas.com Newswire) www.Investorideas.com, a global news source
covering leading sectors including marijuana and hemp stocks and its “potcast’
site, www.potcasts.ca release today’s edition of its series, Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at https://www.investorideas.com/news/2018/cannabis/09051Potcasts-TSX-APH-TRST-CHH-WEED-N.asp
Today’s podcast overview/transcript:
Good morning and welcome to another Investorideas.com potcast – looking
at cannabis news, stocks to watch as well as insights from thought leaders and
experts.
Today we will be looking at announcements from Aphria Inc. trading on
the TSX as APH and US OTC as APHQF, CannTrust Holdings
Inc. trading on the TSX as TRST, Centric Health Corporation trading on the TSX
as CHH, Canopy Growth Corporation trading on the TSX as WEED and the NYSE as
CGC and Namaste Technologies Inc. trading on the TSX-Venture as N.
Aphria Inc. and Rapid Dose Therapeutics Inc., a Canadian bio-technology
company focused on innovative drug delivery solutions, announced today that
they have signed a non-binding Memorandum of Understanding ("MOU") related to RDT's
QuickStrip™ products. Under the terms of the MOU, the companies intend to enter
into a definitive agreement in the near future pursuant to which RDT will
provide Aphria with exclusive global preferred rights to produce, distribute
and sell QuickStrip™ products for cannabis markets around the world.
This proposed strategic partnership highlights Aphria's persistent focus
on innovation with a view to incorporating the latest technologies to
revolutionize the way patients and consumers integrate cannabis into their
lives. RDT's innovative QuickStrip™ is an easy-to-use, safe and effective oral
fast-dissolving drug delivery system, developed in conjunction with McMaster
University through the renowned Adronov Research Group, that provides accurate
dosing and potency. With this technology, Aphria intends to produce oral thin
strips for both the medical and adult-use cannabis markets.
CannTrust Holdings Inc., one of Canada's leading and most trusted
licensed producers of cannabis, announced today that it will collaborate with
Hamilton Health Sciences and McMaster University ("McMaster") in
Hamilton, Ontario on upcoming medical research studies. Hamilton Health
Sciences and McMaster are known world-wide for innovation in education and
research, and for its role in developing evidence-based medicine. This
partnership strengthens CannTrust's existing commitment to innovation and its
contribution to generating evidence regarding the therapeutic use and clinical
effectiveness of cannabinoids.
CannTrust will be working with the Michael G. DeGroote Pain Clinic of
Hamilton Health Sciences and McMaster University, and the Michael G. DeGroote
Institute for Pain Research and Care of McMaster University on a range of
upcoming randomized placebo controlled clinical trials (RCT), representing the
first Canadian University partnership for the Company. Utilizing CannTrust's
broad range of quality cannabis products, the first clinical trial, Cannabis
Oil for Chronic Non-Cancer Pain Treatment (CONCEPT), is expected to begin this
fall, with additional studies to follow.
The results of these studies will be crucial for researchers, health
care practitioners and policy makers to use cannabinoids for designing more
effective, safer treatment protocols and public health policies. Throughout the
partnership, CannTrust will utilize its more than 40 years of pharmacy,
healthcare experience and knowledge to help McMaster and Hamilton Health
Sciences study the application of the Company's products as treatment for
various patient needs.
An analysis of CannTrust's 48,000 existing customer profiles indicates
that pain is one of the primary reasons for utilizing medical cannabis,
highlighting the need for trials in this area. Through research at the Centre,
CannTrust aims to help healthcare professionals and patients better understand
the possible benefits of medical cannabis for those living with pain-related
conditions, and beyond.
Centric Health Corporation today announced that it has entered into
multi-year supply and service agreements with Canopy Growth Corporation for the
provision of medical cannabis. Under the agreements, Canopy Growth will be the
preferred education partner and supplier of choice of medical cannabis
primarily through its Spectrum Cannabis brand to Centric Health and the seniors
that it serves both in long-term care and retirement residences, as well as
seniors living in the community.
Spectrum Cannabis and Centric Health will work collaboratively to
educate Centric Health's clinical pharmacists, as well as other healthcare
partners, residents and seniors and their families, on the benefits and
potential applications of medical cannabis. Centric Health's clinical
pharmacists are in an ideal position to provide guidance on the safe use of
medical cannabis as they are specially trained in geriatric medicine. Many
seniors face significant barriers when it comes to access and knowledge around
the benefits of medical cannabis but with the support of trained pharmacists
and educators, the seniors that Centric Health serves and those living within
the community will have the ability to receive assessments and on-going
support from a pharmacist to ensure the highest degree of safety and
efficacy. Centric Health's unwavering commitment to quality care and resident
outcomes through their existing pharmacy operations and focused strategy of
expanding service offerings to seniors in the community makes for an ideal
long-term strategic partnership.
Namaste Technologies Inc. announced that the Company has achieved a 300%
month-on-month growth rate in its Canadian marketplace, in comparison with
August of 2017, and 50% growth globally. In the month of August of 2018, the
Company generated $1.65M in revenue which represents a 50% increase in revenue
in comparison with August of 2017 after consideration of the loss of revenue
due to Namaste divesting its US assets that were incorporated into its 2017
sales. The Company has also achieved over 300% growth on its Canadian websites,
which now includes over 17,000 customers.
The Company has been focused on developing its Canadian market by
enhancing its e-commerce platform and focusing on organic growth through
content production, search-engine optimization ("SEO") and in
implementation of its proprietary AI technology through the Company's
wholly-owned subsidiary, Findify AB ("Findify" or
"Findify.io"). With increased competition in the Canadian market,
Namaste is pleased to have achieved such significant growth in a key market for
the Company.
In anticipation of receiving Canada's first medical cannabis
"sales-only" license, under the guidelines of Health Canada's ACMPR,
expansion of its Canadian platform including hardware sales as well as
registered users in both NamasteMD ("NamasteMD.com") and My Uppy
Cannabis ("My Uppy") Journal represent significant advances for the
Company as it looks forward to launching cannabis sales into its Canadian
e-commerce marketplace.
Investor ideas reminds
all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy
products or services or securities. Investors are reminded all investment
involves risk and possible loss of investment
Potcasts is now a certified word mark Trademark on the blockchain through
Cognate, Inc. CM Certification
Investorideas.com podcasts are also available on iTunes, Spotify,
Google Play Music, Stitcher, iHeartradio, Spreaker and Tunein.
If you would like to be a guest or sponsor this podcast contact
Investorideas.com
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on
iTunes, Spotify, Google Play Music,
Stitcher, Spreaker, YouTube via
Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word
mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires
Big Investing Ideas
Investorideas.com is a recognized news source
publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and
stock news column, Investor
Ideas #Potcasts #Cannabis News
and Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the Stock Guru daily podcast on Support and Resistance Trading.
Disclaimer/Disclosure: Investorideas.com is
a digital publisher of third party sourced news, articles and equity research
as well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for adherence
in new disclosure filings and filing appropriate documents with Sedar. Read for
more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations
of each country.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
Do you trade or invest in Marijuana / Hemp
Stocks? Check out our stock directory of
publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX
Marijuana / Hemp Stocks
Join our Group on Linkedin and talk about - Marijuana / Hemp Stocks - News and Trends in Green Investing
